Computerized analyses of morphology and proliferative activity differentiate hepatoblastoma from paediatric hepatocellular carcinoma

Histopathology

Volumn 54, Issue 3, 2009, Pages 328-336

  Tsai, Hung Wen ^b   Tsai, Hsun Heng ^c   Kuo, Fang Ying ^d   Chang, Kung Chao ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL PINGTUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Computerized morphometric analysis; Hepatoblastoma; Hepatocellular carcinoma; Morphological criteria; Proliferative index

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

APOPTOSIS; ARTICLE; CANCER CLASSIFICATION; CANCER MORPHOLOGY; CANCER STAGING; CELL PROLIFERATION; CELL STRUCTURE; CHILD; CLINICAL ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; EMBRYONAL TYPE HEPATOBLASTOMA; FEMALE; FETAL TYPE HEPATOBLASTOMA; HEPATOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE PROCESSING; INFANT; INFLAMMATORY CELL; LIVER BIOPSY; LIVER CELL CARCINOMA; LOGISTIC REGRESSION ANALYSIS; MALE; MORPHOMETRICS; MULTIVARIATE ANALYSIS; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROLOGY;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CHILD, PRESCHOOL; COMPUTER SIMULATION; FEMALE; HEPATOBLASTOMA; HUMANS; INFANT; LIVER NEOPLASMS; LOGISTIC MODELS; MALE;

EID: 60349089121     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2009.03232.x     Document Type: Article

References (23)

1. Hamilton SR, Aaltonen LA (eds). Pathology and genetics of tumours of the digestive system. Lyon : IARC Press, 2000 184 189.
2. Douglass EC. Hepatic malignancies in childhood and adolescence (hepatoblastoma, hepatocellular carcinoma, and embryonal sarcoma). Cancer Treat. Res. 1997 92 201 212.
3. Darbari A, Sabin KM, Shapiro CN, Schwarz KB. Epidemiology of primary hepatic malignancies in U.S. children. Hepatology 2003 38 560 566.
4. Exelby PR, Filler RM, Grosfeld JL. Liver tumors in children in the particular reference to hepatoblastoma and hepatocellular carcinoma: American Academy of Pediatrics Surgical Section Survey - 1974. J. Pediatr. Surg. 1975 10 329 337.
5. Suriawinata AA, Thung SN. Malignant liver tumors. Clin Liver Dis 2002 6 527 554.
6. Wang JN, Chen JS, Chuang HY, Yang YJ, Chang KC, Wu JM. Invasion of the cardiovascular system in childhood malignant hepatic tumors. J. Pediatr. Hematol. Oncol. 2002 24 436 439.
7. Sola Perez J, Perez-Guillermo M, Bas Bernal AB, Mercader JM. Hepatoblastoma. An attempt to apply histologic classification to aspirates obtained by fine needle aspiration cytology. Acta Cytol. 1994 38 175 182.
8. Ishak KG, Goodman ZD, Thomas Stocker J (eds). Tumors of the liver and intrahepatic bile ducts. Washington, DC : Armed Forces Institute of Pathology, 2001 159 183.
9. Rosai J. Rosai and Ackerman' s surgical pathology, 9th edn. London : Mosby Press, 2004 1003 1005.
10. Athanassiadou P, Kavantzas N, Gonidi M et al. Correlations between nuclear/cytoplasmic area ratio and classification of cervical smears. J. Exp. Clin. Cancer Res. 2001 20 481 486.
11. Hytiroglou P, Harpaz N, Heller DS, Liu ZY, Deligdisch L, Gil J. Differential diagnosis of borderline and invasive serous cystadenocarcinomas of the ovary by computerized interactive morphometric analysis of nuclear features. Cancer 1992 69 988 992.
12. Ishikawa F, Saito N, Koda K et al. Nuclear morphometric analysis of T2 lesions of the rectum - a simple, reproducible method for predicting malignancy potential. Am. J. Surg. 2002 183 686 691.
13. Lavie O, Maini I, Pilip A et al. Computerized nuclear morphometry for the prediction of inguinal lymph nodes metastases in squamous cell carcinoma of the vulva. Int. J. Gynecol. Cancer 2006 16 556 561.
14. Komitowski D, Janson C, Szamaborski J, Czernobilsky B. Quantitative nuclear morphology in the diagnosis of ovarian tumors of low malignant potential (borderline). Cancer 1989 64 905 910.
15. Rein DT, Schondorf T, Breidenbach M et al. Lack of correlation between P53 expression, BCL-2 expression, apoptosis and ex vivo chemosensitivity in advanced human breast cancer. Anticancer Res. 2000 20 5069 5072.
16. Koskinas J, Petraki K, Kavantzas N, Rapti I, Kountouras D, Hadziyannis S. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma. J. Viral Hepat. 2005 12 635 641.
17. Ishak KG, Glunz PR. Hepatoblastoma and hepatocarcinoma in infancy and childhood. Report of 47 cases. Cancer 1967 20 396 422.
18. Sangkhathat S, Kusafuka T, Miao J et al. In vitro RNA interference against beta-catenin inhibits the proliferation of pediatric hepatic tumors. Int. J. Oncol. 2006 28 715 722.
19. Yamaoka H, Ohtsu K, Sueda T, Yokoyama T, Hiyama E. Diagnostic and prognostic impact of beta-catenin alterations in pediatric liver tumors. Oncol. Rep. 2006 15 551 556.
20. Yamauchi N, Watanabe A, Hishinuma M et al. The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma. Mod. Pathol. 2005 18 1591 1598.
21. Luo JH, Ren B, Keryanov S et al. Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology 2006 44 1012 1024.
22. Ruck P, Xiao JC, Pietsch T, Von Schweinitz D, Kaiserling E. Hepatic stem-like cells in hepatoblastoma: expression of cytokeratin 7, albumin and oval cell associated antigens detected by OV-1 and OV-6. Histopathology 1997 31 324 329.
23. von Schweinitz D, Hecker H, Schmidt-von-Arndt G, Harms D. Prognostic factors and staging systems in childhood hepatoblastoma. Int. J. Cancer 1997 74 593 599.